LOS ANGELES & SINGAPORE--(BUSINESS WIRE)--MedTech Innovator, the world’s largest accelerator of medical technology companies, announced today that 20 medtech companies will participate in the fifth annual Asia Pacific Accelerator program.
“We are delighted to announce this year’s Asia Pacific cohort of companies, representing ten countries and a broad range of technologies and cutting edge innovations. We look forward to working with our partners to support this year’s cohort and to help them advance their technologies and transform the lives of patients not only in the region but potentially worldwide,” said Fredrik Nyberg, Managing Director, MedTech Innovator Asia Pacific.
MedTech Innovator Asia Pacific unites best-in-class startups with investors, business leaders, and allied service professionals in the medtech industry to help drive commercialization of life-changing technologies in the region. The 2024 cohort companies will also compete for up to US$ 300,000 in cash prizes and awards.
More than 400 companies applied for the Asia Pacific program this year, and after a rigorous selection process, 60 companies were invited to pitch, 20 of which were named to the 2024 cohort. The Asia Pacific Accelerator 2024 Cohort will attend the program’s kick off, joining the MedTech Innovator 2024 and the BioTools Cohorts at the invitation-only Innovator Summit 2024 on June 12-13 in San Francisco. This event connects the leadership teams from the latest cohorts with MTI’s partners, alumni, and other industry leaders.
The 20 companies selected to the 2024 MedTech Innovator Asia Pacific Accelerator are:
- Alfaleus Technology, Hyderabad, India
- APrevent, Taipei, Taiwan
- ArmasTec, Singapore
- Ausmed Global, Hong Kong
- CancerFree Biotech, Taipei City, Taiwan and United States
- Endovision, Hong Kong
- Gyder Surgical, California, United States
- Hada MedTech, Ontario, Canada
- INOPASE, Tokyo
- InterMag, Seoul, South Korea
- KA Imaging, Ontario, Canada
- Nanotis, Tokyo
- Niramai Health Analytix, Bengaluru, India
- Padmaseetha Technologies, Chennai, India
- Progressive NEURO, Nebraska, United States
- Promedius, Seoul, South Korea
- Qritive, Singapore
- RNT Health Insights, Chandigarh, India
- Sydney Heart Valve, Sydney, Australia
- Vinbrain Joint Stock Company, Hanoi, Vietnam
MedTech Innovator’s 2024 Asia Pacific program sponsors include Johnson & Johnson, W. L. Gore & Associates, Teleflex, Siemens Healthineers, B Braun Medical, Cambridge Consultants, and Enterprise Singapore. The MedTech Innovator Asia Pacific Program is held in partnership with the Asia Pacific Medical Technology Association (APACMed).
About MedTech Innovator
MedTech Innovator is the world’s largest accelerator of medical technology companies. Its mission is to improve human health by accelerating the growth of companies that are transforming care. MedTech Innovator has been a catalyst for groundbreaking healthcare solutions, reviewing 12,000 applicants and fostering the growth of 612 companies that have collectively raised over $8 billion in follow-on funding and introduced 310 products to the market, transforming the lives of millions.
For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow the U.S. organization at LinkedIn US and its APAC program at LinkedIn APAC, and subscribe to its monthly newsletter.
